Cancer cell with activated RAS pathway

Cancer cells with activated RAS pathways refer to tumor cells in which the **RAS signaling cascade** is constitutively active due to mutations in one or more members of the **RAS gene family**—most commonly KRAS, NRAS, or HRAS. These mutations lead to persistent activation of downstream effectors such as RAF-MEK and PI3K-AKT pathways, driving uncontrolled proliferation, survival, altered metabolism, microenvironmental interactions, and immune evasion. Approximately one-third of all human cancers harbor activating mutations in a member of the RAS gene family; these are especially prevalent in lung adenocarcinoma (~30%), colorectal carcinoma (~40%), and pancreatic ductal adenocarcinoma (>90%). Historically considered "undruggable" due to their structure and function as small GTPases lacking deep binding pockets for inhibitors, recent advances have led to mutation-specific inhibitors such as those targeting **KRAS G12C**, as well as novel approaches that target upstream regulators or downstream effectors like RAF/MEK. However, therapeutic resistance remains a major challenge because blocking one node often leads tumors to reactivate the pathway elsewhere or activate alternative growth signals. Thus combination therapies targeting multiple points within or outside the pathway are under investigation. Note: The term "Cancer cells with activated RAS pathways" describes a cellular state rather than a discrete molecular target; it encompasses any cancerous cell where this oncogenic signal is present. For structured data purposes focused on drug targets at the molecular level—such as "KRas protein," "NRas protein," etc.—it may be preferable to specify individual mutated proteins rather than this broader cellular phenotype.

Other names

RAS-driven cancer cellRAS-mutant cancer cellKRAS/NRAS/HRAS mutant cancer cellOncogenic RAS pathway–activated tumor cell

Direct inhibition of mutant RAS proteins to block downstream signaling; Inhibition of RAF and MEK kinases to disrupt the RAS-MAPK pathway